Susquehanna International Group, LLP Incyte Corp Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $665,028 - $795,876	-11,600 Reduced 12.13%	84,000 $5.55 Million
Q2 2024 Aug 15, 2024	BUY	$51.18 - $63.75 $2.56 Million - $3.19 Million	50,100 Added 110.11%	95,600 $5.8 Million
Q1 2024 May 07, 2024	SELL	$56.55 - $66.59 $7.15 Million - $8.42 Million	-126,400 Reduced 73.53%	45,500 $2.59 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $2.74 Million - $3.38 Million	52,600 Added 44.09%	171,900 $10.8 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $254,188 - $290,092	-4,400 Reduced 3.56%	119,300 $6.89 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $3.96 Million - $4.91 Million	-65,000 Reduced 34.45%	123,700 $7.7 Million
Q1 2023 May 16, 2023	BUY	$70.23 - $86.01 $1.11 Million - $1.36 Million	15,800 Added 9.14%	188,700 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $6.48 Million - $8.12 Million	96,500 Added 126.31%	172,900 $13.9 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $582,384 - $731,984	-8,800 Reduced 10.33%	76,400 $5.8 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $3.1 Million - $3.75 Million	-47,000 Reduced 35.55%	85,200 $6.77 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $3.15 Million - $3.69 Million	49,800 Added 60.44%	132,200 $9.7 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $6,867 - $8,402	-100 Reduced 0.12%	82,400 $5.67 Million
Q2 2021 Aug 11, 2021	SELL	$79.87 - $87.53 $7.16 Million - $7.85 Million	-89,700 Reduced 52.09%	82,500 $6.94 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $5.69 Million - $7.52 Million	-74,800 Reduced 30.28%	172,200 $14 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $2.01 Million - $2.43 Million	-24,900 Reduced 9.16%	247,000 $21.5 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $3.81 Million - $4.91 Million	44,800 Added 19.73%	271,900 $24.4 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $652,784 - $958,584	8,800 Added 4.03%	227,100 $23.6 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.95 Million - $2.66 Million	-30,900 Reduced 12.4%	218,300 $16 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $277,552 - $363,736	3,800 Added 1.55%	249,200 $21.8 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $2.76 Million - $3.28 Million	-37,900 Reduced 13.38%	245,400 $18.2 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $17.5 Million - $21.1 Million	-237,700 Reduced 45.62%	283,300 $24.1 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $11.9 Million - $16.5 Million	-187,600 Reduced 26.47%	521,000 $44.8 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $5.77 Million - $6.9 Million	98,600 Added 16.16%	708,600 $45.1 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $3.43 Million - $4.13 Million	-55,600 Reduced 8.35%	610,000 $42.1 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $25.2 Million - $34.7 Million	-413,700 Reduced 38.33%	665,600 $44.6 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $44.5 Million - $54.1 Million	536,100 Added 98.69%	1,079,300 $89.9 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $10.8 Million - $13.4 Million	115,100 Added 26.89%	543,200 $51.4 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $46.7 Million - $59.2 Million	428,100	428,100 $50 Million

Others Institutions Holding INCY

# of Institutions

641

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account